uridine triphosphate has been researched along with Dry Eye in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Kam, WR; Liu, Y; Sullivan, DA | 1 |
| Hirsh, AJ; Johnson, MR; Kublin, CL; Thelin, WR; Zoukhri, D | 1 |
2 other study(ies) available for uridine triphosphate and Dry Eye
| Article | Year |
|---|---|
Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells?
Topics: Alanine; Antihypertensive Agents; Antioxidants; Antirheumatic Agents; Bimatoprost; Cell Count; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclosporine; Dry Eye Syndromes; Epithelial Cells; Humans; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Meibomian Glands; Quinolones; Signal Transduction; Uridine Triphosphate | 2016 |
Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency.
Topics: Administration, Topical; Amiloride; Animals; Coloring Agents; Diuretics; Dogs; Dry Eye Syndromes; Epithelial Sodium Channels; Female; Fluorescein; Mice; Mice, Inbred BALB C; Purinergic P1 Receptor Antagonists; Sodium Channel Blockers; Tears; Uridine Triphosphate | 2012 |